Drug
Vociprotafib
Vociprotafib: highest development phase Phase 1/2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vociprotafib NCT04418661 | Phase 1/2 | Metastatic Neoplasm |
Latest
No recent events.
Follow Vociprotafib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.